- Home
- EQBK vs QURE Comparison
EQBK vs QURE Comparison
Compare EQBK & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQBK
- QURE
- Stock Information
- Founded
- EQBK 2002
- QURE 1998
- Country
- EQBK United States
- QURE Netherlands
- Employees
- EQBK N/A
- QURE N/A
- Industry
- EQBK Major Banks
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- EQBK Finance
- QURE Health Care
- Exchange
- EQBK Nasdaq
- QURE Nasdaq
- Market Cap
- EQBK 763.9M
- QURE 691.2M
- IPO Year
- EQBK 2015
- QURE 2007
- Fundamental
- Price
- EQBK $42.99
- QURE $12.84
- Analyst Decision
- EQBK Hold
- QURE Strong Buy
- Analyst Count
- EQBK 5
- QURE 8
- Target Price
- EQBK $45.60
- QURE $39.43
- AVG Volume (30 Days)
- EQBK 64.1K
- QURE 798.8K
- Earning Date
- EQBK 04-15-2025
- QURE 03-03-2025
- Dividend Yield
- EQBK 1.37%
- QURE N/A
- EPS Growth
- EQBK 700.00
- QURE N/A
- EPS
- EQBK 4.00
- QURE N/A
- Revenue
- EQBK $220,307,000.00
- QURE $28,587,000.00
- Revenue This Year
- EQBK N/A
- QURE $153.92
- Revenue Next Year
- EQBK $6.39
- QURE N/A
- P/E Ratio
- EQBK $10.89
- QURE N/A
- Revenue Growth
- EQBK 59.51
- QURE N/A
- 52 Week Low
- EQBK $30.44
- QURE $3.73
- 52 Week High
- EQBK $50.85
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- EQBK 45.18
- QURE 38.20
- Support Level
- EQBK $43.01
- QURE $12.72
- Resistance Level
- EQBK $44.03
- QURE $14.42
- Average True Range (ATR)
- EQBK 0.96
- QURE 0.85
- MACD
- EQBK -0.07
- QURE -0.26
- Stochastic Oscillator
- EQBK 31.97
- QURE 7.26
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. The company's operation involves the delivery of loan and deposit products to customers. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.